Low density lipoprotein cholesterol (LDL-C) is widely recognized as an established cardiovascular risk marker. It is used for cardiovascular risk assessment in patients with hypertriglyceridemia, type III hyperlipoproteinemia or dysbetalipoproteinemia. It